As a start-up company in the biotechnology sector, what are the biggest hurdles you face?
Having gone through the hassle of getting the company started, we are now completely focused on the development of our technology. Administrative and financing issues were our main bottlenecks in the initial stages of the project, but we have managed to provide ourselves with the necessary resources. Many small biotech companies are struggling to find a place in the market. In your view, is the market saturated, or are their products and business models simply unviable? The market is becoming increasingly difficult to conquer and this decreases the survival rate of small companies. As the survival threshold rises, only extremely innovative projects and those with a high capacity for networking stay alive. There is disagreement regarding the availability of funds in the sector. Many say that venture capitalists no longer wish to invest in biotechnology, while others maintain that it is one of the best sectors to do so. What is your view? In my experience, venture capitalists remain inte
